| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.741 | 25.367 | 39.640 | 59.377 | 33.276 | 50.908 |
| Total Income - EUR | - | - | - | - | 4.741 | 25.367 | 39.640 | 59.377 | 45.406 | 62.286 |
| Total Expenses - EUR | - | - | - | - | 526 | 35.580 | 32.841 | 45.487 | 40.644 | 41.285 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.215 | -10.213 | 6.799 | 13.891 | 4.761 | 21.002 |
| Net Profit/Loss - EUR | - | - | - | - | 4.073 | -10.449 | 6.429 | 13.297 | 4.375 | 19.413 |
| Employees | - | - | - | - | 0 | 2 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Dr. Mihalcea Lavident S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 80 | 72.674 | 69.829 | 71.492 | 69.790 | 69.904 |
| Current Assets | - | - | - | - | 4.092 | 1.725 | 1.478 | 964 | 4.455 | 6.030 |
| Inventories | - | - | - | - | 193 | 424 | 173 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 948 | 0 | 255 | 0 | 1.040 | 2.175 |
| Cash | - | - | - | - | 2.950 | 1.301 | 1.050 | 964 | 3.415 | 3.855 |
| Shareholders Funds | - | - | - | - | 4.115 | -6.411 | 159 | 13.457 | 17.361 | 36.677 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 57 | 80.811 | 71.147 | 58.999 | 56.884 | 39.256 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Mihalcea Lavident S.r.l.